Sensei Biotherapeutics Inc. (NASDAQ:SNSE) is one of the best performing NASDAQ stocks according to Wall Street analysts. On March 30, Sensei Biotherapeutics shifted its focus following the acquisition of Faeth Therapeutics and a concurrent $200 million private placement. The company’s lead program is now PIKTOR, an all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. This new […]
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
47last 24h
1804last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
Insider Monkey102d agoneutral
Sensei Biotherapeutics (SNSE): Best Performing NASDAQ Stocks According to Wall Street AnalystsPharmaceutical Technology288d agoneutral
Sensei to ditch its lead candidate and cut workforce amidst strategic reviewThe Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.